Barclays Reaffirms Overweight Rating for Assura (LON:AGR)

Barclays reaffirmed their overweight rating on shares of Assura (LON:AGRFree Report) in a research report released on Friday, MarketBeat Ratings reports. Barclays currently has a GBX 53 ($0.67) price objective on the real estate investment trust’s stock.

AGR has been the subject of several other reports. Berenberg Bank lifted their price target on Assura from GBX 49 ($0.62) to GBX 51 ($0.64) and gave the stock a buy rating in a report on Monday, November 20th. Shore Capital initiated coverage on Assura in a research note on Thursday, November 16th. They issued a buy rating on the stock. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to, Assura currently has an average rating of Moderate Buy and a consensus target price of GBX 56.25 ($0.71).

View Our Latest Stock Report on AGR

Assura Stock Down 0.5 %

AGR stock opened at GBX 43 ($0.54) on Friday. The company has a quick ratio of 2.84, a current ratio of 1.29 and a debt-to-equity ratio of 82.21. The business has a 50 day moving average price of GBX 45.64 and a two-hundred day moving average price of GBX 44.62. The company has a market cap of £1.28 billion, a price-to-earnings ratio of -720.00, a P/E/G ratio of 3.60 and a beta of 0.30. Assura has a twelve month low of GBX 38.38 ($0.48) and a twelve month high of GBX 54.60 ($0.69).

Assura Dividend Announcement

The firm also recently disclosed a dividend, which was paid on Wednesday, January 10th. Investors of record on Thursday, December 7th were given a GBX 0.82 ($0.01) dividend. The ex-dividend date of this dividend was Thursday, December 7th. This represents a dividend yield of 1.79%. Assura’s dividend payout ratio (DPR) is presently -5,000.00%.

Insider Buying and Selling at Assura

In other Assura news, insider Jayne Cottam bought 728 shares of the stock in a transaction dated Tuesday, December 5th. The stock was purchased at an average cost of GBX 45 ($0.57) per share, for a total transaction of £327.60 ($413.74). Insiders have bought 1,397 shares of company stock worth $62,811 over the last 90 days. Corporate insiders own 0.24% of the company’s stock.

About Assura

(Get Free Report)

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK – caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.

Further Reading

Analyst Recommendations for Assura (LON:AGR)

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with's FREE daily email newsletter.